366 related articles for article (PubMed ID: 18676361)
21. Genistein induces cell growth inhibition in prostate cancer through the suppression of telomerase activity.
Ouchi H; Ishiguro H; Ikeda N; Hori M; Kubota Y; Uemura H
Int J Urol; 2005 Jan; 12(1):73-80. PubMed ID: 15661057
[TBL] [Abstract][Full Text] [Related]
22. Androgen receptor-dependent PSA expression in androgen-independent prostate cancer cells does not involve androgen receptor occupancy of the PSA locus.
Jia L; Coetzee GA
Cancer Res; 2005 Sep; 65(17):8003-8. PubMed ID: 16140973
[TBL] [Abstract][Full Text] [Related]
23. Regulation of prostate-specific antigen gene expression by an LH-RH analogue in human prostatic cells.
Sica G; Zelano G; Settesoldi D; Iacopino F
Anticancer Res; 2003; 23(2B):1283-7. PubMed ID: 12820384
[TBL] [Abstract][Full Text] [Related]
24. Combined inhibitory effects of soy isoflavones and curcumin on the production of prostate-specific antigen.
Ide H; Tokiwa S; Sakamaki K; Nishio K; Isotani S; Muto S; Hama T; Masuda H; Horie S
Prostate; 2010 Jul; 70(10):1127-33. PubMed ID: 20503397
[TBL] [Abstract][Full Text] [Related]
25. The atypical GATA protein TRPS1 represses androgen-induced prostate-specific antigen expression in LNCaP prostate cancer cells.
van den Bemd GJ; Jhamai M; Brinkmann AO; Chang GT
Biochem Biophys Res Commun; 2003 Dec; 312(3):578-84. PubMed ID: 14680804
[TBL] [Abstract][Full Text] [Related]
26. Expression of interleukin-6 is downregulated by 17-(allylamino)-17-demethoxygeldanamycin in human prostatic carcinoma cells.
Tsui KH; Feng TH; Hsieh WC; Chang PL; Juang HH
Acta Pharmacol Sin; 2008 Nov; 29(11):1334-41. PubMed ID: 18954528
[TBL] [Abstract][Full Text] [Related]
27. Expressional changes after histone deacetylase inhibition by valproic acid in LNCaP human prostate cancer cells.
Thelen P; Schweyer S; Hemmerlein B; Wuttke W; Seseke F; Ringert RH
Int J Oncol; 2004 Jan; 24(1):25-31. PubMed ID: 14654937
[TBL] [Abstract][Full Text] [Related]
28. Androgen-dependent gene expression of prostate-specific antigen is enhanced synergistically by hypoxia in human prostate cancer cells.
Horii K; Suzuki Y; Kondo Y; Akimoto M; Nishimura T; Yamabe Y; Sakaue M; Sano T; Kitagawa T; Himeno S; Imura N; Hara S
Mol Cancer Res; 2007 Apr; 5(4):383-91. PubMed ID: 17426252
[TBL] [Abstract][Full Text] [Related]
29. Inhibition of telomerase activity and secretion of prostate specific antigen by silibinin in prostate cancer cells.
Thelen P; Wuttke W; Jarry H; Grzmil M; Ringert RH
J Urol; 2004 May; 171(5):1934-8. PubMed ID: 15076315
[TBL] [Abstract][Full Text] [Related]
30. Exisulind and related compounds inhibit expression and function of the androgen receptor in human prostate cancer cells.
Lim JT; Piazza GA; Pamukcu R; Thompson WJ; Weinstein IB
Clin Cancer Res; 2003 Oct; 9(13):4972-82. PubMed ID: 14581372
[TBL] [Abstract][Full Text] [Related]
31. Effect of leuprorelin acetate on cell growth and prostate-specific antigen gene expression in human prostatic cancer cells.
Sica G; Iacopino F; Settesoldi D; Zelano G
Eur Urol; 1999; 35 Suppl 1():2-8. PubMed ID: 10081696
[TBL] [Abstract][Full Text] [Related]
32. Sensitive in vitro test systems to determine androgenic/antiandrogenic activity.
Guth SE; Böhm S; Mussler BH; Eisenbrand G
Mol Nutr Food Res; 2004 Sep; 48(4):282-91. PubMed ID: 15497179
[TBL] [Abstract][Full Text] [Related]
33. Triiodothyronine modulates cell proliferation of human prostatic carcinoma cells by downregulation of the B-cell translocation gene 2.
Tsui KH; Hsieh WC; Lin MH; Chang PL; Juang HH
Prostate; 2008 May; 68(6):610-9. PubMed ID: 18196550
[TBL] [Abstract][Full Text] [Related]
34. Curcumin down-regulates AR gene expression and activation in prostate cancer cell lines.
Nakamura K; Yasunaga Y; Segawa T; Ko D; Moul JW; Srivastava S; Rhim JS
Int J Oncol; 2002 Oct; 21(4):825-30. PubMed ID: 12239622
[TBL] [Abstract][Full Text] [Related]
35. Regulation of prostate-specific antigen by activin A in prostate cancer LNCaP cells.
Fujii Y; Kawakami S; Okada Y; Kageyama Y; Kihara K
Am J Physiol Endocrinol Metab; 2004 Jun; 286(6):E927-31. PubMed ID: 14761877
[TBL] [Abstract][Full Text] [Related]
36. Curcumin inhibits human colon cancer cell growth by suppressing gene expression of epidermal growth factor receptor through reducing the activity of the transcription factor Egr-1.
Chen A; Xu J; Johnson AC
Oncogene; 2006 Jan; 25(2):278-87. PubMed ID: 16170359
[TBL] [Abstract][Full Text] [Related]
37. Peroxisome proliferator-activated receptor-gamma and growth inhibition by its ligands in prostate cancer.
Nagata D; Yoshihiro H; Nakanishi M; Naruyama H; Okada S; Ando R; Tozawa K; Kohri K
Cancer Detect Prev; 2008; 32(3):259-66. PubMed ID: 18789607
[TBL] [Abstract][Full Text] [Related]
38. Curcumin provides potential protection against the activation of hypoxia and prolyl 4-hydroxylase inhibitors on prostate-specific antigen expression in human prostate carcinoma cells.
Chung LC; Tsui KH; Feng TH; Lee SL; Chang PL; Juang HH
Mol Nutr Food Res; 2011 Nov; 55(11):1666-76. PubMed ID: 21936051
[TBL] [Abstract][Full Text] [Related]
39. Benzyldihydroxyoctenone, a novel anticancer agent, induces apoptosis via mitochondrial-mediated pathway in androgen-sensitive LNCaP prostate cancer cells.
Moon HS; Lim H; Moon S; Oh HL; Kim YT; Kim MK; Lee CH
Bioorg Med Chem Lett; 2009 Feb; 19(3):742-4. PubMed ID: 19119006
[TBL] [Abstract][Full Text] [Related]
40. [Curcumin inhibits the expression of vascular endothelial growth factor and androgen-independent prostate cancer cell line PC-3 in vitro].
Deng G; Yu JH; Ye ZQ; Hu ZQ
Zhonghua Nan Ke Xue; 2008 Feb; 14(2):116-21. PubMed ID: 18390174
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]